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Abstract 
 
Purpose: The relationship between exposure to abuse and interstitial cystitis/bladder 
pain syndrome (IC/BPS) is well-documented. However, studies have yet to examine 
posttraumatic stress disorder (PTSD), which develops following exposure to trauma and 
worsens health outcomes in chronic pain. We aimed to assess the prevalence and 
impact of PTSD in patients with IC/BPS, including their relation to genitourinary 
symptom presentation and widespread pain phenotype.  
 
Materials and Methods: We recruited 202 participants with chronic pain from an 
academic medical center and classified 64 individuals as IC/BPS based on validated 
epidemiological criteria. Participants completed self-reported questionnaires assessing 
trauma exposure, PTSD symptoms, emotional distress, pain, and urinary symptoms. 
Wilcoxon rank-sum tests assessed study aims comparing IC/BPS to other chronic pain. 
 
Results: Although elevated, IC/BPS trauma exposure rates were equivalent to that of 
other chronic pain conditions in the sample. Despite this equivalence, in comparison, 
IC/BPS patients had significantly higher rates of PTSD symptoms, with 42% meeting 
provisional diagnostic criteria for PTSD. Among IC/BPS, those meeting provisional 
criteria for PTSD had significantly higher incidence of lifetime sexual abuse, childhood 
trauma, and presentations consistent with the widespread pain phenotype. In IC/BPS, 
there was no association between PTSD and genitourinary symptoms, but provisional 
PTSD was associated with more pain, emotional distress, and poorer quality of life.  
 
Conclusions: We recommend that patients with IC/BPS and widespread pain have 
ongoing screening and monitoring of PTSD. We recommend using trauma-informed 
care practices with these patients to increase trust and safety, which could improve 
treatment compliance and follow-up.  
 
Key Words: Interstitial Cystitis; Painful Bladder Syndrome; Posttraumatic Stress 
Disorders; Pain, Chronic; Central Sensitization 
Posttraumatic Stress Disorder in Interstitial Cystitis/Bladder Pain Syndrome: 
Relationship to Widespread Pain and Clinical Practice Recommendations 
 
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a debilitating chronic pain 
condition affecting 3 to 8 million people1 nationally. In addition to bladder-specific 
symptoms, severe psychosocial symptoms can accompany IC/BPS and are associated 
with increased pain, disability, and poly-symptomatic, poly-syndromic complaints driven 
by central sensitization.2-4 Leading researchers propose that individuals with 
widespread, systemic pain represent a distinct (“widespread”) phenotype in IC/BPS 
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compared to those with (“localized”) pain confined to the bladder.2,3 Specifically, those 
with widespread or systemic pain have significantly worsened psychosocial burden.2 As 
such, treatment guidelines encourage a phenotype-directed, multimodal treatment 
approach incorporating medication, minimally invasive intervention, physical therapy, 
psychology, dietary management, and behavioral approaches to manage IC/BPS.26,27  
Abuse exposure is recognized for its negative contribution to IC/BPS. A recent 
meta-analysis4 reported syndrome-specific consequences of trauma exposure in 
IC/BPS patients. For instance, sexual abuse exposure has been related to greater 
sensory pain and fewer urinary symptoms, although some report this relationship as 
modest. A recent study5 indicated that women exposed to trauma in childhood by close 
others had more anxiety, dissociative tendencies, and increased anesthetic bladder 
capacity, proposing that psychosocial factors may drive symptoms in this subset of 
patients.6  
Despite well-known associations between IC/BPS and abuse exposure, there 
has yet to be an investigation into the prevalence and impact of posttraumatic stress 
disorder (PTSD) in IC/BPS. A common misconception equates exposure to trauma with 
PTSD. Epidemiological data indicate that while up to 90% of Americans experience 
some form of trauma of variable severity in their lives, only 8.3% will go on to develop 
PTSD.7 However, the effects of PTSD can be catastrophic. According to the American 
Psychiatric Association, PTSD is a psychiatric disorder that develops following exposure 
to a traumatic event, marked by persistent hyperarousal and reactivity, re-experiencing, 
avoidance of trauma-related stimuli, and negative alteration in cognition and mood for 
one month or more. Symptoms can develop immediately, have delayed onset, and 
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recur at different points when activated by an event that serves as a reminder of the 
initial trauma. In chronic pain conditions that share similar characteristics to IC/BPS, 
PTSD is associated with heightened evoked pain responding and hyper-reactivity to 
noxious stimuli leading to increased chronicity and worsened clinical presentation.8,9 
PTSD and chronic pain are theorized to maintain each other through shared 
mechanisms, such as chronic hyperarousal.8  
To date, we have yet to understand the role that PTSD plays in IC/BPS, even 
though it may have significant clinical and research implications, as urologic care may 
activate PTSD symptoms. Further, we do not know if PTSD worsens symptom 
presentation in IC/BPS or how PTSD relates to IC/BPS phenotypes (e.g. “localized” vs 
“widespread”2,3).  
 To explore how PTSD may affect individuals with IC/BPS, we sought to examine 
the association between PTSD and IC/BPS, including how this may differ from 
individuals with non-IC/BPS chronic pain in a convenience sample of individuals with 
chronic pain. Second, we sought to understand how provisional PTSD diagnosis relates 
to clinical presentation. We hypothesized that (1) individuals with IC/BPS would have 
higher rates of both trauma exposure and PTSD, and that (2) those with both IC/BPS 
and PTSD would exhibit worse health outcomes when compared to participants with 
IC/BPS only. Finally, we (3) examined characteristics of PTSD and pain associated with 
poly-symptomatic, poly-syndromic complaints (i.e., “widespread phenotype”) in IC/BPS.  
Materials and Methods 
The institutional review board reviewed and approved study procedures. We 
recruited consenting participants with chronic pain (N = 211) to complete a series of 
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validated questionnaires (online at home, by paper, or at an on-site computer station) 
assessing physical symptoms, emotional symptoms, and trauma-related experiences 
from 1/2016-3/2017. We identified participants through either a large university-affiliated 
medical outpatient clinic, a hospital-wide research listserv, or via online advertisement 
through ResearchMatch (Figure 1).10 Eligible participants were English-speaking adults 
(>18), and had a “yes” response from either the patient or referring medical provider to 
the question “do you have a medical diagnosis involving chronic pain?” (for 6 months or 
longer). We confirmed the presence of chronic pain via electronic health record review. 
Exclusionary criteria included diagnosis of cognitive or thought disorder, current 
substance dependence, or active suicidal ideation. In total, 202 participants (Mage = 
44.89, 79.7% female) completed the study and comprised the analyzed sample. As we 
recruited our sample through the larger hospital community primarily outside of urology 
specialization, we defined a subset of participants with IC/BPS (n = 64) using RAND 
Interstitial Cystitis Epidemiologic (RICE1) sensitivity criteria, which requires patients to 
report 1) pain, pressure, and discomfort in the pelvic area, 2) daytime frequency of >10, 
and 3) urinary urgency due to pain, pressure, or discomfort (and not fear of wetting). 
Previous investigations11 found that when compared to a clinical cohort, individuals 
meeting RICE sensitivity criteria exhibited remarkably similar demographic and 
symptom profiles, indicating the utility of this approach. 
Measures 
To identify IC/BPS, we used the RICE high sensitivity1 definition (91% sensitivity, 42% 
specificity). We assessed PTSD with the PTSD-Checklist-5 (PCL12), a 20-item self-
report measure corresponding to DSM-5 PTSD diagnostic criteria established by the 
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American Psychiatric Association. Total summed scores  33 indicate a provisional 
PTSD diagnoses.13 We assessed childhood trauma exposure with the Childhood Abuse 
and Trauma Scale (CATS14) and lifetime trauma exposure with the Trauma History 
Questionnaire (THQ15). Given the differing effects of child trauma5 in IC/BPS patients, 
we included an adjusted THQ score for adult trauma only by removing all traumas prior 
to age 18.  
Regarding pain, we used the Numeric Rating Scale (NRS-1116) to assess current 
pain, Michigan Body Map (MBM17) for widespread pain, and central sensitization 
inventory (CSI18). CSI items 11 (dysuria), 21 (urinary frequency) and 25 (pelvic pain) 
examined IC/BPS-specific symptoms. We characterized participants as having likely 
central sensitization (CS) by a validated total cutoff score of  40, which discriminates 
CS from non-CS pain populations.19 We used this cutoff to differentiate individuals with 
likely widespread, systemic pain for our third aim, in which we examined characteristics 
of PTSD and pain associated with the widespread phenotype in IC/BPS. Last, the 
Hospital Anxiety and Depression Scale (HADS20) captured affective distress and 
Satisfaction With Life Scale (SWLS21) quality of life. All measures constitute valid and 
reliable assessments used across previous investigations in IC/BPS and non-cancer 
chronic pain to assess pain and psychosocial functioning.  
Data Analysis 
We conducted analyses using SPSS 25. Due to positive skew, we used Wilcoxon 
rank-sum tests to compare outcome variables by groups for each hypothesis. This 
included examining PTSD and trauma characteristics in IC/BPS versus other chronic 
pain groups (Hypothesis 1); within the IC/BPS group, comparing those with and without 
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PTSD (Hypothesis 2); and when exploring differences between IC/BPS+CS versus 
IC/BPS-only groups (Hypothesis 3). We assigned group membership based on 
validated clinical cutoffs along variables of interest (RICE, PCL, CSI). We used chi-
square analysis with Fisher’s exact test to compare frequencies among categorical 
variables (e.g., gender) by groups. To adjust for multiple comparisons, we used alpha of 
p < .01 (Bonferroni adjustment: 0.05/5=0.01) to define statistical significance. 
Results 
Sample characteristics 
 
The sample (Table 1) was largely female (79.7%) and white (81.2%), with 
diverse educational and vocational status. Men were significantly older than women 
(Mmen = 49.8, Mwomen = 43.8). Women endorsed higher levels of widespread pain (MBM: 
z = 3.12, p = .002), total central sensitization (CSI: z = 2.91, p = .004), and dysuria (z = 
3.05, p = .002) than men. Women reported higher rates of childhood neglect (CATS: z = 
-2.01, p = .045), while men endorsed more general disaster/traumas (THQ: z = -2.01, p 
= .045). Men and women did not differ on other variables.  
Trauma Exposure and PTSD in IC/BPS 
 Patients with likely IC/BPS were significantly younger than those with other forms 
of chronic pain and displayed higher levels of central sensitization, PTSD symptoms, 
anxiety, and depression (Table 2). Patients with likely IC/BPS did not differ in exposure 
to trauma in childhood or adulthood when compared to other chronic pain. 
PTSD and health outcomes in IC/BPS 
 Patients with co-occurring IC/BPS and provisional PTSD reported poorer health 
functioning broadly. The co-occurrence group endorsed higher levels of current pain, 
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central sensitization, childhood trauma, lifetime physical/sexual trauma, anxiety, 
depression, and quality of life than IC/BPS patients without PTSD (Table 3). IC/BPS 
patients with PTSD did not differ in reported dysuria, pelvic pain, frequency, or on the 
remaining variables. 
Widespread pain phenotype in IC/BPS 
 Patients with co-occurring IC/BPS and CS endorsed higher levels of current and 
widespread pain, PTSD symptoms, and all forms of emotional distress than IC/BPS 
patients without CS (Table 4). The groups did not differ on other variables. Given the 
similarity between IC/BPS+PTSD and IC/BPS+CS groups, we examined overlap 
between group memberships (Figure 2); all individuals in the IC/BPS+PTSD group fell 
into the IC/BPS+CS group (25 of 51 individuals), while only 50% of IC/BPS+CS patients 
met criteria for provisional PTSD (similar to the 42% rate for IC/BPS alone). Notably, 
this overlap was consistent across all domains of PTSD symptoms.  
 
Discussion 
 
In this cohort of individuals with chronic pain conditions, individuals with IC/BPS did not 
differ in their lifetime exposure to trauma, including sexual abuse and physical abuse, 
compared to those with other chronic pain. However, in spite of equivalent trauma 
exposure, participants with IC/BPS exhibited significantly higher rates of PTSD 
symptoms and psychosocial distress. This suggests that it may not be trauma exposure, 
but individuals’ reactions to trauma that are a source of distress for this population.  
 When examining the IC/BPS cohort separately, 42% of individuals with IC/BPS 
met provisional PTSD criteria (PCL-5  33). Not only is this roughly five times that 
reported in the general population,7 it is two times higher than non-IC chronic pain 
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participants in our sample (23%). A recent systematic review22 also found that certain 
pain subtypes (e.g., fibromyalgia, low back pain) have significantly elevated PTSD 
rates. Furthermore, individuals with IC/BPS and co-occurring provisional PTSD reported 
higher rates of pain, psychosocial distress, greater exposure to lifetime sexual or 
physical abuse, and childhood trauma. Although overall pain levels were higher, PTSD 
was not associated with an altered IC/BPS presentation with respect to urinary urgency, 
frequency, or pelvic pain. This negative finding coincides with previous reports of the 
“widespread” IC/BPS phenotype, where patients have higher rates of polysymptomatic 
complaints, psychosocial distress, and pain levels but do not differ based on urinary 
symptoms.2  
 In this sample, IC/BPS patients exposed to childhood abuse were more likely to 
meet criteria for PTSD. While childhood sexual abuse contributes, it does not fully 
explain the effect, and other aspects of negative or hostile home environments play a 
role. Since relational or childhood trauma by close others significantly impacts patient 
psychosocial and bladder functioning, this prompts further investigation. Further, 
although they did not formally assess PTSD, Chiu and colleagues (2017) found that 
dissociation, characteristic of PTSD, was associated with childhood trauma. Together, 
this may provide preliminary evidence of a relevant aspect in clinical profiles of a subset 
of IC/BPS patients.  
 We assessed whether individuals with IC/BPS and provisional PTSD exhibited 
characteristics of the “widespread” IC/BPS phenotype – polysymptomatic, 
polysyndromic complaints suggesting central sensitization (CS). Though not 
significantly linked to specific trauma exposure, the widespread phenotype was 
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associated with higher levels of both current and widespread pain (a median of 12 pain 
sites compared to 1 pain site) and greater PTSD symptoms and psychological 
impairment. All individuals with IC/BPS+PTSD fell within the widespread phenotype, 
which comprised roughly 50% of the group, suggesting that over and above trauma 
exposure, PTSD is uniquely related to this phenotypic presentation of IC/BPS. However, 
given the small size of the comparison group (with no CS), further research is needed to 
confirm this finding.  
 
Clinical Practice Implications 
 
International guidelines26 recommend regular and ongoing assessment of the negative 
psychological consequences of IC/BPS and psychological distress in relation to pain. As 
little information exists about the management of PTSD in relation to patient 
presentation, evaluation, and management in IC/BPS (i.e. phenotype-directed 
treatment26), we seek to offer suggestions for practice that may be beneficial to patient-
provider interactions, treatment, and the patient experience. We suggest the following 
principles of trauma informed care23 in the treatment of IC/BPS. They emphasize strong 
patient-centered communication and behavioral techniques to establish patient-provider 
trust and rapport, reduce anxiety, and increase perceived control during appointments:  
PTSD Screening: Previous studies indicate that individuals with IC/BPS report 
abuse at significantly lower rates when asked directly by medical providers.24 
Consequently, we recommend initially assessing PTSD through monitoring specific 
symptoms over direct questioning (e.g., hyper-arousal, nightmares), specifically for 
patients with widespread pain presentations given its overlap with PTSD.  
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Initial appointment and ongoing management: Encouraging trauma survivors to 
collaborate in their appointments may lead to higher perceived control and trust.23 We 
suggest offering patients an overview of what will happen during the initial visit, 
including procedures involved. We provide suggestions to enhance perceived safety 
during examination or procedures in Table 5. Pelvic floor physical therapy (PFPT) can 
trigger PTSD symptoms.25 If a patient has PTSD and is emotionally distressed, PFPT 
may be contra-indicated until the patient has adequate support. 
Study Strengths and Limitations 
This is the first study to our knowledge using validated measures to assess PTSD 
symptoms and likely PTSD diagnoses in IC/BPS, while also considering trauma 
exposure. Along with prevalence, this assessment enabled us to differentiate whether 
PTSD symptoms, not just trauma exposure, were associated with IC/BPS group 
membership. We used a clinical sample with a chronic pain comparison group, which 
may increase validity of our findings. We used validated clinical cutoffs consistent with 
PTSD and medical diagnoses to improve accuracy, clinical applicability, and 
reproducibility of this work. 
Study limitations include reliance on a single major academic medical center and 
cross-sectional data. We did not collect information on symptom duration beyond 6 
months. Our IC/BPS group sample size was relatively small, especially those without 
concurrent CS (n = 9), potentially leading to decreased power in group comparisons. 
However, this is reasonable given the low prevalence of IC/BPS. Also our IC/BPS group 
was younger and more likely female than the other chronic pain group; although this 
demographic composition mirrors population data on IC/BPS and recent investigations,5 
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group demographic differences may confound results. We used epidemiological criteria 
to identify likely cases of IC/BPS, as the majority of patients were seen outside of 
urology. Future investigations would reduce the potential for misclassification with 
formal evaluation by a urologist. We assessed bladder-specific symptoms between 
groups with specific CSI items. We would have preferred to use in-depth scales 
validated for this reason specifically. Information bias limits retrospective recall of 
traumatic events. While a diagnostic clinical interview is preferred in PTSD assessment, 
investigations show marked variability in participants’ willingness to acknowledge abuse 
exposure in person and this may remain a standing limitation in this line of research 
without longitudinal study. Furthermore, although growing evidence indicates the 
reliability and validity of online questionnaire administration, reliance on online self-
report surveys may limit the clinical applicability of our results. Lastly, trauma-informed 
care practice guidelines have yet to be studied in IC/BPS.  
Future Research 
Replication and extension of these findings, particularly in terms of PTSD prevalence, is 
needed with larger clinical samples. Future investigations may explore the role of PTSD 
from childhood trauma in IC/BPS symptom development and maintenance, using 
structured diagnostic assessment tools. As PTSD symptom reduction in similar chronic 
pain conditions can lead to pain reduction and improved outcomes, it may be a fruitful 
area of investigation in clinical trials.  
Conclusions 
Although individuals with IC/BPS did not differ in their exposure to abuse compared to 
other chronic pain conditions, those with IC/BPS had significantly higher likelihood of 
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PTSD, particularly when exposed to childhood trauma. Our investigation highlights the 
high potential for PTSD in IC/BPS (42%) and the strong associations between 
concurrent IC/BPS and PTSD and both symptoms and quality of life. PTSD also 
appears associated with the “widespread” pain phenotype and merits consideration for 
multimodal treatment in these patients.   
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Table 1 Demographic characteristics by presence or absence of IC/BPS 
Group Total Sample  
(N = 202) 
Chronic Pain 
(n = 137) 
IC/BPS + 
(n = 64) 
  
Demographics M SD M SD M SD t p 
Age 44.89 14.23 47.04 14.00 40.14 13.73 3.25 .001 
         
 n % n % n % χ2 p 
Gender       6.11 .01 
Women 161 79.7 104 75.9 56 87.5   
Men 36 17.8 31 22.6 5 7.8   
Unknown 5 2.5 2 1.5 3 4.7   
Race       4.81 .68 
African American, Black 17 8.4 11 8.0 6 9.4   
Asian/Pacific Islander 4 2.0 3 2.2 1 1.6   
Hispanic, Latina/o 5 2.5 3 2.2 2 3.1   
Native American/American Indian 1 0.5 1 0.7 0 0.0   
White 164 81.2 113 82.5 50 78.1   
Multiracial 6 3.0 2 1.5 4 6.3   
Other  4 1.9 3 2.2 1 1.6   
Unknown 1 0.5 1 0.7 0 0.0   
Relationship Status       9.01 .06 
Single 53 26.2 31 22.6 22 34.4   
Married/Domestic Partnership 108 53.5 82 59.9 25 39.1   
Divorced 36 17.8 20 14.6 16 25.0   
Separated 4 2.0 3 2.2 1 1.6   
Widowed 1 0.5 1 0.7 0 0.0   
Educational Attainment       1.47 .96 
High school diploma or equivalent 15 7.4 10 7.3 5 7.8   
Vocational or technical school 8 4.0 5 3.6 3 4.7   
Some college 40 19.8 26 19.0 13 20.3   
Bachelor’s degree 70 34.7 49 35.8 21 32.8   
Master’s degree 44 21.8 29 21.2 15 23.4   
Doctorate or professional degree 17 8.4 11 8.0 6 9.4   
Other 7 3.5 6 4.4 1 1.6   
Unknown 1 0.5 1 0.7 0 0.0   
Employment Status       7.33 .20 
Full-time 106 52.5 74 54.0 32 50.0   
Part-time 18 8.9 12 8.8 6 9.4   
Self-employed 9 4.5 8 5.8 1 1.6   
Unemployed 10 5.0 5 3.6 5 7.8   
Retired 20 9.9 16 11.7 4 6.3   
Unable to work 37 18.3 20 14.6 16 25.0   
Unknown 2 1.0 2 1.5 0 0.0   
Income       14.71 .02 
Under $10,000 8 4.0 3 2.2 5 7.8   
$10,000-19,999 16 7.9 8 5.8 8 12.5   
$20,000-$50,000 48 23.8 29 21.2 19 29.7   
$50,000-$100,000 55 27.2 43 31.4 11 17.2   
$100,000-$150,000 36 17.8 27 19.7 9 14.1   
$150,000 or higher 15 7.4 13 9.5 2 3.1   
Unknown 24 11.9 14 10.2 10 15.6   
Disability Status       9.45 .009 
Currently receiving disability 33 16.3 24 17.5 8 12.5   
In the process of applying for disability 16 7.9 5 3.6 11 17.2   
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Not receiving or applying for disability 113 55.9 75 54.7 38 59.4   
Unknown 40 19.8 32 23.4 7 10.9   
Note. M = mean; SD = standard deviation; n = frequency of demographic characteristic; % = percentage of 
subgroup. Statistical tests evaluate differences in distributions of each demographic variable by IC/BPS 
group. Fisher’s exact test p-values reported (two-tailed test) for all chi-square analyses. Significant tests at 
p < .01 are denoted by bold font. 
Table 2 Pain, trauma, and distress by IC/BPS and other chronic pain groups 
Group Chronic Pain IC/BPS   
N (%) 137 (67.8) 64 (31.7)   
Outcome n (F) % (F) n (F) % (F) χ2 p φ
Gender 104 76 56 88 6.11 .02 .18
         
 M Med SD M Med SD z p η
Age 47.04 50 14.00 40.14 37 13.73 -3.16 .002 .05
Pain         
Current Pain (NRS-11) 4.46 5 2.36 4.64 5 2.67 0.46 .54 .001
Widespread Pain (MBM) 9.09 7 6.97 10.22 10 7.70 0.76 .45 .003
Central Sensitization (CSIA) 42.78 45 16.09 57.03 57 17.12 5.06 <.001 .14
Dysuria (CSIA-11) 0.37 0 0.74 1.76 2 1.41 7.32 <.001 .27
Urination Frequency (CSIA-21) 1.10 1 1.10 2.52 3 1.16 7.05 <.001 .25
Pelvic Pain (CSIA-25) 0.85 0 1.15 2.30 2 1.25 7.07 <.001 .25
Trauma         
Childhood Trauma Exposure (CATS) 39.83 29.5 28.87 46.99 38 29.07 1.89 .06 .02
Childhood Sexual Abuse 1.55 0 2.77 2.16 0 3.47 1.01 .31 .005
Lifetime Trauma Exposure (THQ) 5.82 5 3.96 5.60 5 3.97 -0.32 .75 <.001
Physical/Sexual Trauma 1.03 1 1.39 1.11 1 1.15 1.09 .28 .006
Adult Trauma Exposure (THQ-r) 3.28 3 2.67 3.06 3 2.59 -1.32 .19 .009
Adult Physical/Sexual Trauma 0.32 0 0.66 0.44 0 0.67 1.52 .13 .01
PTSD Symptoms (PCL-5) 19.92 16.5 15.14 29.77 24 20.97 2.86 .004 .05
Emotional Distress         
Anxiety (HADS-A) 8.53 8 4.36 10.92 10 4.98 3.20 .001 .05
Depression (HADS-D) 6.43 6 4.16 8.17 9 4.80 2.58 .01 .03
Quality of Life (SWLS) 20.07 21 7.63 17.59 16 8.26  -1.92 .06 .02
Note. All group comparisons conducted using the nonparametric Wilcoxon rank-sum test, except gender. Group 
comparisons on gender conducted using Chi-square contingency table analysis with Fisher’s exact test. Significant 
tests at p < .01 are denoted by bold font. IC/BPS = interstitial cystitis/bladder pain syndrome; F = female; M = mean; 
Med = median; SD = standard deviation; NRS = Numeric Rating Scale; MBM = Michigan Body Map; CSIA = Central 
Sensitization Inventory—Part A; CATS = Child Abuse and Trauma Scale; THQ = Trauma History Questionnaire; THQ-r 
= revised THQ after removing childhood trauma exposure; PTSD = posttraumatic stress disorder; PCL = PTSD 
Checklist for DSM-5; PCS = Pain Catastrophizing Scale; HADS = Hospital Anxiety and Depression Scale; SWLS = 
Satisfaction With Life Scale.   
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Table 3 Pain, trauma, and distress by IC/BPS and IC/BPS plus PTSD groups 
Group IC/BPS Only IC/BPS + PTSD   
N (%) 35 (17.3) 25 (12.4)   
Outcome n (F) % (F) n (F) % (F) χ2 p 
Gender 31 86 21 85 0.00 1.00 
         
 M Med SD M Med SD z p 
Age 39.41 35.5 14.32 42.08 41 12.35 1.20 .23 
Pain         
Current Pain (NRS-11) 3.89 4 2.83 5.84 6 2.08 2.68 .007 
Widespread Pain (MBM) 9.26 9 7.9 11.48 13 7.48 1.23 .22 
Central Sensitization (CSIA) 49.33 53 16.06 67.5 67.5 13.58 3.84 <.001 
Dysuria (CSIA-11) 1.65 2 1.32 1.76 2 1.54 0.19 .85 <.001
Urination Frequency (CSIA-21) 2.34 2 1.26 2.75 3 1.07 1.24 .22 
Pelvic Pain (CSIA-25) 2.29 2 1.22 2.24 2 1.33 -0.37 .71 .002
Trauma         
Childhood Trauma Exposure (CATS) 33.62 25.33 23.27 64.63 66 26.14 4.13 <.001 
Childhood Sexual Abuse 1.29 0 2.72 3.36 2 4.07 2.55 .01 
Lifetime Trauma Exposure (THQ) 4.40 4 2.89 7.08 7 4.10 2.49 .01 
Physical/Sexual Trauma 0.69 0 0.87 1.71 2 1.12 3.50 <.001 
Adult Trauma Exposure (THQ-r) 2.60 3 1.99 3.68 3 2.87 1.36 .18 
Physical/Sexual Trauma 0.34 0 0.59 0.54 0 0.72 1.11 .27 
PTSD Symptoms (PCL-5) 14.97 15 11.27 48.72 45 14.01 6.07 <.001 
Emotional Distress         
Anxiety (HADS-A) 8.40 8 4.05 14.48 16 4.27 4.54 <.001 
Depression (HADS-D) 5.43 5 3.66 11.86 12 3.81 5.10 <.001 
Quality of Life (SWLS) 21.65 23 7.47 12.38 11 6.27 -4.27 <.001 
Note. All group comparisons conducted using the nonparametric Wilcoxon rank-sum test, except gender. Group 
comparisons on gender conducted using Chi-square contingency table analysis with Fisher’s exact test. Significant 
tests at p < .01 are denoted by bold font. IC/BPS = interstitial cystitis/bladder pain syndrome; PTSD = posttraumatic 
stress disorder; F = female; M = mean; Med = median; SD = standard deviation; NRS = Numeric Rating Scale; MBM = 
Michigan Body Map; CSIA = Central Sensitization Inventory—Part A; CATS = Child Abuse and Trauma Scale; THQ = 
Trauma History Questionnaire; THQ-r = revised THQ after removing childhood trauma exposure; PCL = PTSD 
Checklist for DSM-5; PCS = Pain Catastrophizing Scale; HADS = Hospital Anxiety and Depression Scale; SWLS = 
Satisfaction With Life Scale.   
 
 
Table 4 Pain, trauma, and distress by IC/BPS and IC/BPS plus central sensitization (CS) groups 
Group IC/BPS Only IC/BPS + CS    
N (%) 9 (4.5) 51 (25.2)    
Outcome n (F) % (F) n (F) % (F) χ2 p φ
Gender 8 89 45 88 0.27 .51 .07
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 M Med SD M Med SD z p η2
Age 39.22 32 16.29 39.12 3.65 12.57 -0.23 .82 <.001
Pain          
Current Pain (NRS-11) 1.56 1 2.01 5.16 5 2.44 3.49 <.001 .21
Widespread Pain (MBM) 1.89 1 1.36 11.67 12 7.61 3.68 <.001 .23
Central Sensitization (CSIA) 27.67 29 9.00 62.22 59 12.27 4.75 <.001 .38
Dysuria (CSIA-11) 1.78 2 1.39 1.78 2 1.43 -0.01 .99 <.001
Urination Frequency (CSIA-21) 2.00 2 1.00 2.73 3 1.08 2.00 .05 .07
Pelvic Pain (CSIA-25) 2.11 2 1.36 2.32 2 1.24 0.30 .77 .002
Trauma          
Childhood Trauma Exposure (CATS) 28.11 13 22.66 49.99 43 28.65 2.20 .03 .08
Childhood Sexual Abuse 0.44 0 0.73 2.48 0 3.71 1.31 .19 .03
Lifetime Trauma Exposure (THQ) 2.78 2 2.11 5.72 5 3.75 2.26 .02 .09
Physical/Sexual Trauma 0.56 0 0.73 1.18 1 1.14 1.52 .13 .04
Adult Trauma Exposure (THQ-r) 1.89 1 1.96 2.94 2.5 2.42 1.19 .23 .02
Physical/Sexual Trauma 0.22 0 0.44 0.46 0 0.68 0.91 .36 .01
PTSD Symptoms (PCL-5) 3.43 4 2.23 33.74 33 19.82 3.97 <.001 .30
Emotional Distress          
Anxiety (HADS-A) 6.22 6 2.99 11.92 11 4.83 3.32 <.001 .19
Depression (HADS-D) 2.11 2 2.15 9.43 9 4.29 4.23 <.001 .31
Quality of Life (SWLS) 27.11 29 5.62 16.04 14 7.65 -3.57 <.001 .22
Note. All group comparisons conducted using the nonparametric Wilcoxon rank-sum test, except gender. Group 
comparisons on gender conducted using Chi-square contingency table analysis with Fisher’s exact test. Significant 
tests at p < .01 are denoted by bold font. IC/BPS = interstitial cystitis/bladder pain syndrome; CS = central 
sensitization; F = female; M = mean; Med = median; SD = standard deviation; NRS = Numeric Rating Scale; MBM = 
Michigan Body Map; CSIA = Central Sensitization Inventory—Part A; CATS = Child Abuse and Trauma Scale; THQ = 
Trauma History Questionnaire; THQ-r = revised THQ after removing childhood trauma exposure; PTSD = 
posttraumatic stress disorder; PCL = PTSD Checklist for DSM-5; PCS = Pain Catastrophizing Scale; HADS = Hospital 
Anxiety and Depression Scale; SWLS = Satisfaction With Life Scale.   
 
 
Table 5: Trauma-Informed Care Practices as Applied to Patient Examination Procedures (adapted from 
Elliot et al, 2005) 
Prior to 
Examination* 
• Obtain consent: provide patient with a choice of whether or not to proceed with 
exam, and medical rationale for why it may be helpful 
• Provide details and parameters of exam, such as specific procedures, 
timeframe, duration, and objective 
• Ask if patient would like a support person present 
• Ask if steps can be taken to increase comfort 
• Provide patient with choice about clothing, body position, use of stirrups 
• Establish a verbal (word) or non-verbal (foot wiggle, arm raising) signal to 
indicate stopping the exam, when medically possible 
• Allow patient to ask questions and clarify as able 
• Develop a plan of active coping techniques to use during the examination (e.g. 
deep breathing) 
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During 
Examination 
• Inform patient when examination is starting 
• Check-in with patient regularly  
• Speak in a calm voice 
• Continue to remind patient of parameters, such as the steps you are taking 
during the exam 
• Maintain awareness of signal and respect patient’s wishes if stopping is 
requested. In the event that this is not medically safe, inform the patient that the 
examination will cease as soon as you are able 
• Encourage and reinforce active coping techniques 
After 
Examination 
• Encourage and reinforce active coping techniques 
• Summarize findings, write them down for the patient if possible 
• Allow patient to ask further questions 
*Note: the care practices suggested above in examinations are interchangeable with diagnostic testing, 
treatment, and procedures. 
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